» Articles » PMID: 39695964

Decoding the Enigmatic Estrogen Paradox in Pulmonary Hypertension: Delving into Estrogen Metabolites and Metabolic Enzymes

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Pulmonary hypertension (PH) presents a puzzling sex bias, being more prevalent in women yet often less severe than in men, and the underlying reasons remain unclear. Studies using animal models, and limited clinical data have revealed a protective influence of exogenous estrogens, known as the estrogen paradox. Research suggests that beyond its receptor-mediated effects, estrogen acts through metabolites such as 2-ME2, 4-OHE2, and 16-OHE2, which are capable of exhibiting protective or detrimental effects in PH, prompting the need to explore their roles in PH to untangle sex differences and the estrogen paradox. Hypoxia disrupts the balance of estrogen metabolites by affecting the enzymes responsible for estrogen metabolism. Delving into the role of these metabolic enzymes not only illuminates the sex difference in PH but also provides a potential rationale for the estrogen paradox. This review delves into the intricate interplay between estrogen metabolites, metabolic enzymes, and PH, offering a deeper understanding of sex-specific differences and the perplexing estrogen paradox in the context of this condition.

References
1.
Cracowski J, Chabot F, Labarere J, Faure P, Degano B, Schwebel C . Proinflammatory cytokine levels are linked to death in pulmonary arterial hypertension. Eur Respir J. 2013; 43(3):915-7. DOI: 10.1183/09031936.00151313. View

2.
Durrington H, Upton P, Hoer S, Boname J, Dunmore B, Yang J . Identification of a lysosomal pathway regulating degradation of the bone morphogenetic protein receptor type II. J Biol Chem. 2010; 285(48):37641-9. PMC: 2988369. DOI: 10.1074/jbc.M110.132415. View

3.
Pokreisz P, Fleming I, Kiss L, Barbosa-Sicard E, Fisslthaler B, Falck J . Cytochrome P450 epoxygenase gene function in hypoxic pulmonary vasoconstriction and pulmonary vascular remodeling. Hypertension. 2006; 47(4):762-70. PMC: 1993904. DOI: 10.1161/01.HYP.0000208299.62535.58. View

4.
Culley M, Chan S . Mitochondrial metabolism in pulmonary hypertension: beyond mountains there are mountains. J Clin Invest. 2018; 128(9):3704-3715. PMC: 6118596. DOI: 10.1172/JCI120847. View

5.
Zhao M, Ma J, Li M, Zhang Y, Jiang B, Zhao X . Cytochrome P450 Enzymes and Drug Metabolism in Humans. Int J Mol Sci. 2021; 22(23). PMC: 8657965. DOI: 10.3390/ijms222312808. View